Brain+ A/S
Quotes
Share:
Subscribe:
news.cision.com
/
Brain+ A/S
/
Brain+ is experiencing growing interest from big pharma in its Digital Therapeutics solutions for dementia
/
1 B EN RGB
1 B EN RGB
Tue, Aug 02, 2022 08:30 CET
new
Low resolution
Medium resolution
Original resolution
Subscribe
Related Releases
Brain+ fully on track towards market entry and first sales in the United Kingdom in H2 2024
Fri, Aug 23, 2024 08:50 CET
New UK Labour government will focus on healthtech and dementia treatment as part of UK healthcare reform
Fri, Jul 12, 2024 10:31 CET
The CST Assistant v2.0 for Cognitive Stimulation Therapy (CST) now released in Denmark
Tue, Jul 09, 2024 10:18 CET